L-selectin-dependent and -independent homing of naïve lymphocytes through the lung draining lymph node support T cell response to pulmonary Mycobacterium tuberculosis infection

PLoS Pathog. 2023 Jul 5;19(7):e1011460. doi: 10.1371/journal.ppat.1011460. eCollection 2023 Jul.

Abstract

Recruiting large numbers of naïve lymphocytes to lymph nodes is critical for mounting an effective adaptive immune response. While most naïve lymphocytes utilize homing molecule L-selectin to enter lymph nodes, some circulating cells can traffic to the lung-draining mediastinal lymph node (mLN) through lymphatics via the intermediate organ, lung. However, whether this alternative trafficking mechanism operates in infection and contributes to T cell priming are unknown. We report that in pulmonary Mycobacterium tuberculosis-infected mice, homing of circulating lymphocytes to the mLN is significantly less efficient than to non-draining lymph node. CD62L blockade only partially reduced the homing of naïve T lymphocytes, consistent with L-selectin-independent routing of naïve lymphocytes to the site. We further demonstrated that lymphatic vessels in infected mLN expanded significantly and inhibiting lymphangiogenesis with a vascular endothelial growth factor receptor 3 kinase inhibitor reduced the recruitment of intravenously injected naïve lymphocytes to the mLN. Finally, mycobacterium-specific T cells entering via the L-selectin-independent route were readily activated in the mLN. Our study suggests that both L-selectin-dependent and -independent pathways contribute to naïve lymphocyte entry into mLN during M. tuberculosis infection and the latter pathway may represent an important mechanism for orchestrating host defence in the lungs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • L-Selectin / metabolism
  • Lung
  • Lymph Nodes
  • Lymphocytes
  • Mice
  • Mycobacterium tuberculosis*
  • T-Lymphocytes
  • Tuberculosis* / metabolism
  • Tuberculosis, Pulmonary*
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • L-Selectin
  • Vascular Endothelial Growth Factor A

Grants and funding

This work was supported by a National Health and Medical Research Council (NHMRC) of Australia Project grant APP1146677 (C.G.F) and Centre of Research Excellence in Tuberculosis Control APP11534934 (W.J.B). L.D. and N.D.B. were supported by Australian Postgraduate Awards. The funders had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.